About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 352091, 14 pages
http://dx.doi.org/10.1155/2012/352091
Research Article

Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice

1Department of Phamacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
2Pharmaceutical Research Center, Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
3Department of Pharmaceutical Biotechnology, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
4Biotechnology Research Center and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
5Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
6Department of Pathology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
7Medical Toxicology Research Center and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran

Received 16 August 2012; Revised 12 November 2012; Accepted 15 November 2012

Academic Editor: Khalid Rahman

Copyright © 2012 Elahe Taghiabadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Stevens and C. S. Maier, “Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease,” Molecular Nutrition and Food Research, vol. 52, no. 1, pp. 7–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Faroon, N. Roney, J. Taylor, A. Ashizawa, M. H. Lumpkin, and D. J. Plewak, “Acrolein health effects,” Toxicology and Industrial Health, vol. 24, no. 7, pp. 447–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Luo, B. G. Hill, Y. Gu et al., “Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure,” American Journal of Physiology, vol. 293, no. 6, pp. H3673–H3684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. V. J. Feron, H. P. Til, F. De Vrijer, R. A. Woutersen, F. R. Cassee, and P. J. Van Bladeren, “Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment,” Mutation Research, vol. 259, no. 3-4, pp. 363–385, 1991. View at Scopus
  5. D. P. Ghilarducci and R. S. Tjeerdema, “Fate and effects of acrolein,” Reviews of Environmental Contamination and Toxicology, vol. 144, pp. 95–146, 1995. View at Scopus
  6. M. A. Ismahil, T. Hamid, and P. Haberzettl, “Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy,” American Journal of Physiology, vol. 301, no. 5, pp. H2050–H2060, 2011.
  7. K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa, “Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production,” Journal of Biological Chemistry, vol. 274, no. 4, pp. 2234–2242, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Luo and R. Shi, “Acrolein induces oxidative stress in brain mitochondria,” Neurochemistry International, vol. 46, no. 3, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Wang, Y. Sun, M. Asahi, and K. Otsu, “Acrolein, an environmental toxin, induces cardiomyocyte apoptosis via elevated intracellular calcium and free radicals,” Cell Biochemistry and Biophysics, vol. 61, no. 1, pp. 131–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Srivastava, B. Chandrasekar, A. Bhatnagar, and S. D. Prabhu, “Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase,” American Journal of Physiology, vol. 283, no. 6, pp. H2612–H2619, 2002. View at Scopus
  11. K. K. Griendling and G. A. FitzGerald, “Oxidative stress and cardiovascular injury—part II: animal and human studies,” Circulation, vol. 108, no. 17, pp. 2034–2040, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. V. P. M. van Empel, A. T. Bertrand, R. J. van Oort et al., “EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant,” Journal of the American College of Cardiology, vol. 48, no. 4, pp. 824–832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Pugazhenthi, K. Phansalkar, G. Audesirk, A. West, and L. Cabell, “Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal,” Free Radical Biology and Medicine, vol. 40, no. 1, pp. 21–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tanel and D. A. Averill-Bates, “Activation of the death receptor pathway of apoptosis by the aldehyde acrolein,” Free Radical Biology and Medicine, vol. 42, no. 6, pp. 798–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Orrenius and B. Zhivotovsky, “The future of toxicology—does it matter how cells die?” Chemical Research in Toxicology, vol. 19, no. 6, pp. 729–733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Karimi, M. Vahabzadeh, P. Lari, M. Rashedinia, and M. Moshiri, “Silymarin, a promising pharmacological agent for treatment of diseases,” Iranian Journal of Basic Medical Sciences, vol. 14, no. 4, pp. 308–317, 2011. View at Scopus
  18. H. Malekinejada, A. Rezabakhsha, F. Rahmanib, and R. Hobbenaghic, “Silymarin regulates the cytochrome P450 3A2 and glutathione peroxides in the liver of streptozotocin-induced diabetic rats,” Phytomedicine, vol. 19, no. 7, pp. 583–590, 2012.
  19. F. Nazemian, G. Karimi, M. Moatamedi, S. Charkazi, J. Shamsara, and A. H. Mohammadpour, “Effect of silymarin administration on TNF-α serum concentration in peritoneal dialysis patients,” Phytotherapy Research, vol. 24, no. 11, pp. 1654–1657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Chen, T. S. Huang, C. H. Wong et al., “Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells,” Food and Chemical Toxicology, vol. 47, no. 3, pp. 638–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Fleming, PDR for Herbal Medicines, New Jersy Medical Economics Company, 2000.
  22. G. Karimi, M. Ramezani, and Z. Tahoonian, “Cisplatin nephrotoxicity and protection by milk thistle extract in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 383–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. H. H. Mansour, F. Hafez, and N. M. Fahmy, “Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats,” Journal of Biochemistry and Molecular Biology, vol. 39, no. 6, pp. 656–661, 2006. View at Scopus
  24. N. A. El-Shitany, S. El-Haggar, and K. El-desoky, “Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2422–2428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Tunca, M. Sozmen, M. Citil, M. Karapehlivan, S. Erginsoy, and K. Yapar, “Pyridine induction of cytochrome P450 1A1, iNOS and metallothionein in Syrian hamsters and protective effects of silymarin,” Experimental and Toxicologic Pathology, vol. 61, no. 3, pp. 243–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Patel, C. Joseph, G. B. Corcoran, and S. D. Ray, “Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver,” Toxicology and Applied Pharmacology, vol. 245, no. 2, pp. 143–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. E. S. E. El-Awady, Y. M. Moustafa, D. M. Abo-Elmatty, and A. Radwan, “Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies,” European Journal of Pharmacology, vol. 650, no. 1, pp. 335–341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. T. Hariri, S. A. Moallem, M. Mahmoudi, B. Memar, and H. Hosseinzadeh, “Sub-acute effects of diazinon on biochemical indices and specific biomarkers in rats: protective effects of crocin and safranal,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2803–2808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. W. G. Niehaus and J. R. B. Samuelsson, “Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation,” European Journal of Biochemistry, vol. 6, no. 1, pp. 126–130, 1968. View at Scopus
  30. M. S. Moron, J. W. Depierre, and B. Mannervik, “Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver,” Biochimica et Biophysica Acta, vol. 582, no. 1, pp. 67–78, 1979. View at Scopus
  31. P. Manna, M. Sinha, and P. C. Sil, “Amelioration of cadmium-induced cardiac impairment by taurine,” Chemico-Biological Interactions, vol. 174, no. 2, pp. 88–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Herman, R. Mhatre, I. P. Lee, J. Vick, and V. S. Waravdekar, “A comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys,” Pharmacology, vol. 6, no. 4, pp. 230–241, 1971. View at Scopus
  33. S. J. Korsmeyer, “BCL-2 gene family and the regulation of programmed cell death,” Cancer Research, vol. 59, no. 7, pp. 1693s–1700s, 1999. View at Scopus
  34. B. Liu, Z. Jian, Q. Li, et al., “Baicalein protects human melanocytes from H2O2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway,” Free Radical Biology and Medicine, vol. 53, no. 2, pp. 183–193, 2012.
  35. J. Roy, P. Pallepati, A. Bettaieb, A. Tanel, and D. A. Averill-Bates, “Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells,” Chemico-Biological Interactions, vol. 181, no. 2, pp. 154–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. D. Yuan, G. Z. Jin, and G. C. Piao, “Hepatoprotective effects of an active part from Artemisia sacrorum Ledeb. against acetaminophen-induced toxicity in mice,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 528–533, 2010.
  37. A. S. Sreedhar and P. Csermely, “Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy—a comprehensive review,” Pharmacology and Therapeutics, vol. 101, no. 3, pp. 227–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. D. Adams Jr. and L. K. Klaidman, “Acrolein-induced oxygen radical formation,” Free Radical Biology and Medicine, vol. 15, no. 2, pp. 187–193, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. J. P. Kehrer and S. S. Biswal, “The molecular effects of acrolein,” Toxicological Sciences, vol. 57, no. 1, pp. 6–15, 2000. View at Scopus
  40. G. Ramakrishnan, H. R. B. Raghavendran, R. Vinodhkumar, and T. Devaki, “Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats,” Chemico-Biological Interactions, vol. 161, no. 2, pp. 104–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Arumugam, V. Sivakumar, J. Thanislass, K. Sadasivan Pillai, S. Niranjali Devaraj, and H. Devaraj, “Acute pulmonary toxicity of acrolein in rats-underlying mechanism,” Toxicology Letters, vol. 104, no. 3, pp. 189–194, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Feng, Z. Liu, X. Li et al., “α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells,” Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1222–1231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Pradeep, C. V. R. Mohan, K. Gobianand, and S. Karthikeyan, “Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats,” European Journal of Pharmacology, vol. 560, no. 2-3, pp. 110–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. A. Elberry, A. B. Abdel-Naim, E. A. Abdel-Sattar et al., “Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats,” Food and Chemical Toxicology, vol. 48, no. 5, pp. 1178–1184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. M. Muley, V. N. Thakare, R. R. Patil, A. D. Kshirsagar, and S. R. Naik, “Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: a comparative evaluation with piracetam and protocatachuic acid,” Pharmacology Biochemistry and Behavior, vol. 102, no. 2, pp. 286–293, 2012.
  46. M. E. Shaker, G. E. Shiha, and T. M. Ibrahim, “Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis,” European Journal of Pharmacology, vol. 670, no. 2-3, pp. 593–600, 2011.
  47. P. J. O'Brien, D. E. C. Smith, T. J. Knechtel et al., “Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals,” Laboratory Animals, vol. 40, no. 2, pp. 153–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Fadeel, S. Orrenius, and B. Zhivotovsky, “Apoptosis in human disease: a new skin for the old ceremony?” Biochemical and Biophysical Research Communications, vol. 266, no. 3, pp. 699–717, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Kumar and S. L. Sitasawad, “N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells,” Life Sciences, vol. 84, no. 11-12, pp. 328–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Hu, S. Zhou, and X. Li, “Altered Bcl-2 and Bax expression is associated with cultured first trimester human cytotrophoblasts apoptosis induced by hypoxia,” Life Sciences, vol. 79, no. 4, pp. 351–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. G. Shalan, M. S. Mostafa, M. M. Hassouna, S. E. H. El-Nabi, and A. El-Refaie, “Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements,” Toxicology, vol. 206, no. 1, pp. 1–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Kalmar and L. Greensmith, “Induction of heat shock proteins for protection against oxidative stress,” Advanced Drug Delivery Reviews, vol. 61, no. 4, pp. 310–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Ahmed, A. K. Tripathi, S. G. Suke et al., “Role of HSP27 and reduced glutathione in modulating malathion-induced apoptosis of human peripheral blood mononuclear cells: ameliorating effect of N-acetylcysteine and curcumin,” Toxicology in Vitro, vol. 23, no. 7, pp. 1319–1325, 2009. View at Publisher · View at Google Scholar · View at Scopus